MediciNova Establishes Flexible At-The-Market Equity Program
I'm PortAI, I can summarize articles.
MediciNova, Inc. has established an equity distribution agreement with Lucid Capital Markets, allowing it to sell up to $50 million of common stock through at-the-market offerings. Lucid will act as the sales agent, earning a 3.0% commission, while MediciNova retains discretion over sales timing and pricing. The program offers flexible access to equity capital as needed. The latest analyst rating for MNOV stock is a Buy with a $5.00 price target, and the company has a market cap of $62.42 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments